News | TaiRx, Inc. | New Drug Development

TaiRx received Honorable award at the 2015 Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Award Competition.

2015/9/24 […]

TaiRx received Honorable award at the 2015 Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Award Competition. Chang Lisa 2021-02-17T13:44:45+00:00

TaiRx received the Bronze Award at the 2015 Taipei Biotech Award Competition.

2015/7/24 Bio@Taipei […]

TaiRx received the Bronze Award at the 2015 Taipei Biotech Award Competition. Chang Lisa 2021-02-17T13:48:45+00:00

CVM-1118 IND approved by the US FDA to initiate Phase I clinical study in US.

2015/5/13 CVM-1118 from TaiRx, Inc. receives US FDA approval to initiate Phase I clinical study. TaiRx’s IND application received its approval in 30 days [...]

CVM-1118 IND approved by the US FDA to initiate Phase I clinical study in US. Chang Lisa 2018-06-04T17:51:46+00:00

TaiRx signed research contract with Northwestern University Ann & Robert H. Lurie Children’s Hospital of Chicago to evaluate Nodal, a novel oncology target

2014/3/14 […]

TaiRx signed research contract with Northwestern University Ann & Robert H. Lurie Children’s Hospital of Chicago to evaluate Nodal, a novel oncology target Chang Lisa 2018-06-04T17:51:53+00:00

TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.

2014/1/10 MoneyDJ […]

TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. Chang Lisa 2021-02-17T13:53:31+00:00

Industrial Bank of Taiwan, China Development Industrial Bank, Daiwa Securities Group Inc., and Diamond BioFund Inc. raise over ten billion NTD for Biotech.

2013/12/2 […]

Industrial Bank of Taiwan, China Development Industrial Bank, Daiwa Securities Group Inc., and Diamond BioFund Inc. raise over ten billion NTD for Biotech. Chang Lisa 2021-02-17T14:29:53+00:00